Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Acromegaly and pituitary gigantism |
French
|
Acromégalie et gigantisme |
| Level | Code | Title | |
|---|---|---|---|
| 1 | IV | Endocrine, nutritional and metabolic diseases | |
| 2 | E20-E35 | Disorders of other endocrine glands | |
| 3 | E22 | Hyperfunction of pituitary gland | |
| 4 | E22.0 | Acromegaly and pituitary gigantism |
| Active Ingredient | Description | |
|---|---|---|
| Bromocriptine |
Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications. |
|
| Pegvisomant |
Pegvisomant is an analogue of human growth hormone that has been genetically modified to be a growth hormone receptor antagonist for the treatment of adult patients with acromegaly. Pegvisomant is highly selective for the GH receptor, and does not cross-react with other cytokine receptors, including prolactin. |
